Skip to main content
. 2024 Mar 14;25(6):3278. doi: 10.3390/ijms25063278

Figure 1.

Figure 1

IBD-specific risk factors for liver steatosis. Steatotic liver disease in IBD patients results from a series of factors that are not yet fully elucidated. Drugs, gut microbiota, parenteral nutrition, disease activity, and duration, as well as surgical resections, may yield an effect on liver disease, but many questions about liver steatosis pathogenesis in this subset of patients are still unanswered.